Ziritaxestat Clinical Trials Discontinued

Ziritaxestat Clinical Trials Discontinued

286170

Ziritaxestat Clinical Trials Discontinued

Galapagos NV and Gilead Sciences are discontinuing all clinical trials with the investigational medication ziritaxestat. This includes the long-term extension of the Phase 2a NOVESA trial in scleroderma, as well as the Phase 3 ISABELA program in idiopathic pulmonary fibrosis (IPF). The decision is based on the recommendations of the ISABELA trials’ Independent Data Monitoring Committee (IDMC), which, after reviewing interim data, concluded the benefit-risk profile of the investigational medication did not support further clinical…

You must be logged in to read/download the full post.